BioStock: Promore Pharma advancing according to plan

The reporting season is in full swing, and biopharmaceutical company Promore Pharma has now joined the list of companies that have reported on the second quarter. CEO Jonas Ekblom emphasises that the first months of the year have been characterised by intensive work that has resulted in the company advancing its two candidates according to plan. BioStock took the opportunity to ask Ekblom three quick questions about the report.

Read the article at biostock.se:

https://www.biostock.se/en/2022/09/promore-pharma-advancing-according-to-plan/

This is a press release from BioStock - Connecting Innovation & Capital. https://www.biostock.se/en/